Europlasma S.A. buy krebskrebs
Start price
25.01.21
/
50%
€18,400
Target price
25.01.22
€100,000
Performance (%)
-94.46%
End price
26.01.22
€1,020.0
Summary
This prediction ended on 26.01.22 with a price of €1,020.0. Massive losses of -94.46% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Europlasma S.A. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by krebskrebs for this prediction
In the thread Europlasma S.A. diskutieren
In the thread Trading Europlasma S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten